Since the antioxidant properties of the C-6 were successfully halting neurodegeneration by the inhibition of NOX-1 and -2 expression under the protein aggregate-mediated oxidative stress, the C-6 can be a potent neuroprotective/-recovery agent that can be further investigated as a potential therapeutic for PD treatment. Here, NOX1 is linked to Parkinson disease.